# Arthurian Life Sciences

Arthurian Life Sciences is a Private Equity based in London, United Kingdom.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** London, United Kingdom
- **Region:** Europe
- **Address:** London, United Kingdom
- **Founded:** 2013
- **Assets under management:** Undisclosed
- **Website:** arthurianlifesciences.co.uk
- **LinkedIn:** linkedin.com/company/arthurian-life-science

## Regulatory record

- **Reports private funds:** No

## About

Arthurian Life Sciences is a specialist fund management company acting as General Partner of the Wales Life Sciences Investment Fund, a £100 million fund investing in life sciences companies globally. The fund focuses on investments with a meaningful impact in Wales. Arthurian has made 3 investments, including Apitope in 2015, and 1 portfolio exit, Apitope in 2021.

## Sectors

- Healthcare Services
- Digital Health
- Pharmaceuticals & Biotech

## Questions

### What investment stages does Arthurian Life Sciences target?

The firm targets the full life-sciences lifecycle: early-stage seed rounds, startup and expansion phases, and spin-offs from academic institutions and research centers. This spans preclinical assets through to late-stage commercial opportunities. The broad mandate allows the firm to remain invested across multiple value-creation inflection points.

### Which geographies does Arthurian Life Sciences focus on?

The firm is headquartered in London and invests primarily across Europe, with an emphasis on the United Kingdom and continental European innovation hubs. The UK's Golden Triangle — London, Oxford, and Cambridge — represents a natural sourcing corridor given the density of university research output and life-sciences spin-outs in the region.

### What sectors does Arthurian Life Sciences invest in?

Arthurian concentrates exclusively on the life-sciences sector, including therapeutics, medical devices, diagnostics, digital health, and healthcare IT. The firm does not diversify into unrelated technology verticals or generalist private equity, making it a pure-play allocation for institutional investors seeking dedicated biotech and medtech exposure.

### Does Arthurian Life Sciences operate as a venture capital fund or a private equity firm?

Arthurian functions as a private equity firm with a strategy that blends venture capital-style early-stage investing and late-stage private equity deployment. The firm engages in direct equity investments, structured spin-off transactions, and venture rounds rather than operating a fund-of-funds or purely passive LP model.

## Related profiles

- [Arth Capital](https://altss.com/profile/arth-capital)
- [Asadel Partners Private Equity](https://altss.com/profile/asadel-partners-private-equity)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/arthurian-life-sciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology